Trial Profile
A Phase 1, Cross-over, Randomized, Single-dose Open Label Study To Determine The Effect Of Food On The Pharmacokinetics Of Orally Administered Pf-06372865 In Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Oct 2014
Price :
$35
*
At a glance
- Drugs Darigabat (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 24 Oct 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 20 Aug 2014 New trial record